Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity

Regnier, M.; Polizzi, A.; Smati, S.; Lukowicz, C.; Fougerat, A.; Lippi, Y.; Fouche, E.; Lasserre, F.; Naylies, C.; Betoulieres, C.; Barquissau, V.; Mouisel, E.; Bertrand-Michel, J.; Batut, A.; Al Saati, T.; Canlet, C.; Tremblay-Franco, M.; Ellero-Simatos, S.; Langin, D.; Postic, C.; Wahli, W.; Loiseau, N.; Guillou, H.; Montagner, A.

doi:10.1101/488031

Home/Archive/bioRxiv

bioRxiv · 10.1101/488031

Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity

View original source ↗Export metadata ↓

Abstract

ObjectivesPeroxisome proliferator activated receptor (PPAR) acts as a fatty acid sensor to orchestrate the transcription of genes coding for rate-limiting enzymes required for lipid oxidation in hepatocytes. Mice only lacking Ppar in hepatocytes spontaneously develop steatosis without obesity in aging. Altough steatosis is a benign condition it can develop into non alcoholic steatohepatitis (NASH), which may progress to irreversible damage, such as fibrosis and hepatocarcinoma. While NASH appears as a major public health concern worldwide, it remains an unmet medical need. Several drugs are being tested in clinical trials, including pharmacological agonists for the different PPAR isotypes. In current study, we investigated the role of hepatocyte PPAR in a preclinical model of steatosis.\n\nMethods/ResultsWe have investigated the role of hepatocyte PPAR in a preclinical model of steatosis using High Fat Diet (HFD) feeding as a model of obesity in C57BL/6J male Wild-Type mice (WT), in whole-body (Ppar-/-) mice and in mice lacking Ppar in hepatocyte (Pparhep-/-). We provide evidence that Ppar deletion in hepatocytes promotes NASH in mice fed an HFD. This enhanced NASH susceptibility occurs without development of glucose intolerance. Moreover, our data reveal that non-hepatocytic PPAR activity predominantly contributes to the metabolic response to HFD.\n\nConclusionTaken together, our data support hepatocyte PPAR as being essential to the prevention of steatosis progression to NASH and that extra-hepatocyte PPAR activity contributes to whole-body lipid homeostasis.\n\nHighlightsO_LIPpar deletion in hepatocytes promotes steatosis and inflammation in HFD-induced obesity\nC_LIO_LIHepatocyte-specific deletion of Ppar dissociates NAFLD from glucose intolerance in HFD-induced obesity obesity\nC_LIO_LIExtrahepatic PPAR activity contributes to the metabolic response to HFD-induced obesity\nC_LI

Explore related subjects

pathology Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Regnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouche, E., Lasserre, F., Naylies, C., Betoulieres, C., Barquissau, V., Mouisel, E., Bertrand-Michel, J., Batut, A., Al Saati, T., Canlet, C., Tremblay-Franco, M., Ellero-Simatos, S., Langin, D., Postic, C., Wahli, W., Loiseau, N., Guillou, H., Montagner, A.. 2018-12-06. Hepatocyte-specific deletion of Pparα promotes NASH in the context of obesity. https://doi.org/10.1101/488031

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Failed allogeneic corneal lenticules show fibrosis and identity loss without dominant T cell rejection

Failed allogeneic corneal stromal lenticules develop progressive opacity, but the state of the implanted tissue is unknown. Here we show that six explants from three patients occupy a fibrotic integration-failure state with scar-matrix production and loss of corneal identity without a dominant T cell rejection program. Scar-matrix, transparency and corneal-identity programs separated every patient from eight unimplanted donor controls, the last defined by independent human single-cell references. Calibrated immune programs and repertoire reconstruction distinguished the explants from canonical adaptive rejection. Exchange reduced interface reflectivity initially, followed by recurrent opacity in two patients and corneal steepening with declining uncorrected acuity in the third. In non-scarring rabbit repair, identity moved toward the uninjured state as backscatter returned toward normal despite increasing similarity to the explant-derived expression signature. Within one culture experiment, marked scar suppression accompanied opposite identity responses. Tacrolimus and rapamycin likewise suppressed canonical rejection while moving identity in opposite directions. Resveratrol combined reduced scar-associated programs and increased identity with improved graft appearance in the source study. These findings establish classic-rejection activity and tissue integration as separable axes and direct treatment of failed lenticules from escalating immunosuppression toward control of stromal remodeling and preservation of corneal identity.

pathology↗

bioRxiv2026

Hypoxemia is an Independent Risk Factor for Perioperative Thrombosis at High Altitude: A Retrospective Study of 11,084 Patients

Objective Perioperative thrombosis occurs at a significantly higher rate at high altitudes compared to low altitudes, severely threatening the safety of surgical patients. This study aims to determine the independent risk factors for perioperative thrombosis in high-altitude environments, providing a scientific basis for early clinical screening and targeted intervention. Methods Clinical data from 11,084 surgical patients were retrospectively analyzed. Patients were categorized into thrombosis and non-thrombosis groups based on the occurrence of postoperative thrombosis. Baseline characteristics, operative variables, and laboratory indicators were collected, encompassing 21 potential risk factors including arterial partial pressure of oxygen (PaO2). Univariate analysis and multivariate logistic regression (forward stepwise likelihood ratio method) were performed using SPSS 27.0 to identify independent risk factors for perioperative thrombosis. The predictive performance of the model was evaluated using receiver operating characteristic (ROC) curves, decision curve analysis (DCA), calibration plots, and nomograms. Results Of the 11,084 patients, 1,631 (14.7%) developed thrombosis. Univariate analysis showed that varicose veins, hemoglobin levels, Preoperative hospital stay, body mass index (BMI), D-dimer, partial pressure of oxygen, and interleukin-6 were significantly associated with thrombosis (P < 0.05). Multivariate logistic regression identified varicose veins,Preoperative hospital stay, elevated BMI, erythrocytosis, elevated D-dimer, hypoxemia, and elevated interleukin-6 as independent risk factors for thrombosis (P < 0.05). The predictive model demonstrated strong discrimination, with an area under the curve (AUC) of 0.862 (95% CI: 0.848-0.876), a sensitivity of 0.790, and a specificity of 0.773. Among the individual risk factors, hypoxemia exhibited the highest diagnostic performance, yielding an AUC of 0.732 and a sensitivity of 0.763. Conclusion The incidence of perioperative thrombosis at high altitudes is elevated, with hypoxemia serving as an independent predictor beyond traditional risk factors. Clinical management should prioritize correcting pre- and postoperative hypoxic states. Furthermore, implementing individualized prophylaxis that accounts for other risk factors such as multiple surgeries, advanced age, anemia, and coagulation-fibrinolysis system abnormalities is crucial to mitigating thrombotic risk.

pathology↗

bioRxiv2026

Transmural Single-Nucleus Transcriptomics Nominates Candidate Disease Programs in Human Necrotizing Enterocolitis

Background & Aims: Necrotizing enterocolitis (NEC) is a life-threatening disease of premature infants marked by inflammation, ischemia, mucosal injury, and, in advanced cases, necrosis extending into deeper layers of the intestinal wall. Because NEC affects specialized, interacting cells in a developing intestine, we used single-nucleus transcriptomics to build a transmural, cell-type-resolved map and nominate hypothesis-generating disease programs distinct from maturation. Methods: Full-thickness intestinal specimens from fetal/prenatal controls, acute NEC cases, and infant controls were analyzed by single-nucleus RNA sequencing (snRNA-seq). Fetal and infant samples served as developmental references. Analyses included cell annotation, NEC-versus-infant differential expression, gene ontology (GO), cross-lineage recurrence, cell death signatures, and developmental maturity. Results: We profiled 53,735 nuclei by snRNA-seq and resolved 34 epithelial, stromal, vascular, immune, neuronal, glial, and smooth muscle populations. We used a morphology-based nuclei scoring system for sample selection that predicted high-quality transcript recovery. NEC nuclei were represented across this cellular landscape, with recurrent gene-expression changes suggesting shared inflammatory recruitment, antimicrobial/redox defense, stress adaptation, complement/vascular activation, reduced homeostatic signaling, and cell death-associated regulation. Developmental maturity analysis identified fetal-like expression levels in subsets of NEC-regulated genes. Proliferative crypt populations retained DNA repair/cell-cycle programs with inflammatory, hypoxic, and ER-stress features, while absorptive enterocytes showed reduced digestive, transport, detoxification, and terminal villus-function programs. Secretory-lineage changes implicated goblet mucus-barrier responses with reduced glycosylation, trafficking, and hydration; enteroendocrine changes in epithelial defense, metabolic stress, and neural signaling; and Paneth cell retention of antimicrobial effector transcripts despite altered ER quality control, autophagy, and granule delivery in NEC. Non-epithelial programs implicated stromal Wnt/BMP niche loss, impaired lymphatic drainage/scavenging, macrophage cytokine activation with reduced clearance machinery, neuroglial circuit defects, and altered smooth muscle contraction-relaxation balance. Conclusions: This single nuclear intestinal cell atlas nominates multicellular programs that may govern NEC initiation, progression toward tissue destruction, and resolution toward functional recovery.

pathology↗